The Net Margin of BrightGene Bio-Medical Technology Co Ltd (688166.SS) is 14.75%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 14.75% |
| 2023-12-31 | 17.17% |
| 2022-12-31 | 23.55% |
| 2021-12-31 | 23.18% |
| 2020-12-31 | 21.63% |
| 2019-12-31 | 22.08% |
| 2018-12-31 | 17.96% |
| 2017-12-31 | 14.49% |
| 2016-12-31 | 8.51% |